• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE EVERFLX; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE EVERFLX; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number PRP35-08040120V01
Device Problems Premature Activation (1484); Failure to Advance (2524)
Patient Problem Injury (2348)
Event Date 12/15/2014
Event Type  Injury  
Event Description
The procedure was transverse sinus vein stenting, performed in (b)(6).The protege everflex stent did not cross, and started to deploy when advancing.The stent was removed because it began to deploy before reaching the target area.Patient injury reported.Current condition is stable.The patient was brought back the next day and a jugular vein puncture was performed and another self expanding stent was used through a 7f sheath.
 
Manufacturer Narrative
A review of the manufacture records for this device did not reveal any discrepancies relevant to the reported event.
 
Manufacturer Narrative
This supplemental mdr is being submitted as a part of a retrospective review / remediation effort performed at the covidien (b)(4) location, following medtronic¿s acquisition of covidien.A capa has been opened to manage the actions related to remediation of complaint files and any required mdr reporting.
 
Event Description
Evaluation summary: the protege everflex stent delivery system (sds) was received for evaluation with the distal 1/2 cell (1 strut level) deployed.No ancillary devices or cine images from the procedure were available for this investigation.The lock-mechanism was snug-tight.The strut level was significantly deformed as was the distal edge of the sds outer sheath.The cause of the deformation could not be determined.The device was flushed and loaded into the deployment force fixture.The stent deployed with 0.62 lbs.Of force (design specification: { 3.0 lbs.).The distal deployment paddle was removed from the manifold assembly and the inner shaft was pulled back to expose the hypotube section normally secured by the lock thumb-screw.The hypotube component exhibited two witness marks indicating that it had been locked by the manifold thumbscrew.The distal tip was drawn up to the outer sheath distal tip.The tip was introduced into a 6fr gage.The tip would pass through the gage but the (deformed) distal edge of the outer sheath would catch on the gage edge.The maximum width over the sheaths distal edge was 0.0805 and the maximum width proximal to the noted deformation was 0.0785.Note: it should be noted that the protege everflex is not approved for use in the jugular vein.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE EVERFLX
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie riley
4600 nathan lane n
plymouth, MN 55442
7633987000
MDR Report Key4423719
MDR Text Key5279798
Report Number2183870-2015-00012
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative,company representati
Reporter Occupation Other
Type of Report Initial
Report Date 12/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/14/2015
Device Model NumberPRP35-08040120V01
Device Catalogue NumberPRP35-08040120V01
Device Lot Number9829457 EXP. DT.14.11.2015
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/16/2014
Initial Date FDA Received01/15/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/14/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age10 YR
-
-